IMUNON CEO Issues Letter to Shareholders
Reviews 2022 accomplishments; sets forth 2023 milestones and long-term vision LAWRENCEVILLE, N.J., March 01, 2023…
Month: March 2023
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions”…
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions”…
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
Allogene Therapeutics Announces Publication of Industry-Advancing Case Study on Chromosomal Rearrangement in Molecular Therapy
Publication Reviews Investigation of a Chromosomal Rearrangement Observed in a Single Patient Receiving Gene-Edited Allogeneic…
Allogene Therapeutics Announces Publication of Industry-Advancing Case Study on Chromosomal Rearrangement in Molecular Therapy
Publication Reviews Investigation of a Chromosomal Rearrangement Observed in a Single Patient Receiving Gene-Edited Allogeneic…
Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
BOSTON, March 01, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
BOSTON, March 01, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
MINNEAPOLIS, March 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
MINNEAPOLIS, March 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
WILMINGTON, Del., March 01, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a…
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
WILMINGTON, Del., March 01, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a…
ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx’s Entry into a Services Agreement with iNGENu CRO Pty Ltd
Glen Rock, N.J., March 01, 2023 (GLOBE NEWSWIRE) — ResolutionRx Ltd (“ResolutionRx”), an unlisted public…
ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx’s Entry into a Services Agreement with iNGENu CRO Pty Ltd
Glen Rock, N.J., March 01, 2023 (GLOBE NEWSWIRE) — ResolutionRx Ltd (“ResolutionRx”), an unlisted public…
Coherus BioSciences to Present at Upcoming Investor Conferences in March
REDWOOD CITY, Calif., March 01, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS)…
Coherus BioSciences to Present at Upcoming Investor Conferences in March
REDWOOD CITY, Calif., March 01, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS)…
Verizon continues to upgrade Lancaster’s best network
Recent upgrades lead to testing results that show customers in Lancaster have the best experience…
Verizon continues to upgrade Lancaster’s best network
Recent upgrades lead to testing results that show customers in Lancaster have the best experience…
Verizon continues to upgrade Louisville’s best network
Recent upgrades lead to testing results that show customers in Louisville have the best experience…